D-830-2013 Class II Terminated
FDA drug recall D-830-2013 was initiated by Torrent Pharma Inc on Jul 22, 2013 and is designated Class II. Reason for recall: Defective Container; This action is being taken as a precautionary measure due to the product being re-packaged in the U.S. using a filler material that (removes or blocks) less moisture than what is… The recall status is terminated (terminated Jan 31, 2014). Affected quantity: 18,721 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 7, 2013
- Initiation Date
- Jul 22, 2013
- Termination Date
- Jan 31, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 18,721 bottles
Product description
Olanzapine Tablets, USP, 10 mg, Rx Only, 30 tablets per bottle, Mfd for: Prasco Laboratories, Mason OH, 45040, USA, Mfd by: Torrent Pharmaceuticals Ltd., Indrad-382 721, Dist. Mehsana India, NDC 66993-463-30
Reason for recall
Defective Container; This action is being taken as a precautionary measure due to the product being re-packaged in the U.S. using a filler material that (removes or blocks) less moisture than what is approved in the application.
Distribution pattern
Nationwide
Code information
Lot #: BS392004A, Exp: 09/2014
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-830-2013
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026